EIC Fund

Activity from announced rounds

Activity in this selectionSeries B

The EIC Fund is the European Innovation Council’s venture investment arm, financed by the European Commission to help European deep-tech startups and scaleups commercialise breakthrough technologies.

It combines patient capital with co-investment from private investors, with investment advice from the European Investment Bank. The purpose is to bridge financing gaps for technologies that need substantial development before reaching the market.

Its sector scope includes advanced materials and manufacturing, energy and climate, biotechnology, medical technology, quantum computing, semiconductors and space. Founders approach it through the EIC funding framework, with the investment component supporting the commercial growth of selected innovative companies.

Sources
Rounds participated in
5
Confirmed lead rounds
0
2 roles undisclosed
New companies
5
First participation on record · 0 follow-on
Funding in participating rounds
$401.2M
4 disclosed · full round size, not this investor’s share

By stage

Series B5

By primary sector

Climate tech2
Hardware1
Healthtech1
Industrial tech1

By country

Netherlands2
France1
Germany1
Spain1

Rounds

5 in this selection
Reverion

Reversible solid oxide fuel cell power plants that generate dispatchable electricity from gas and can store surplus power as storable gas.

$175MSeries B
Participant
Morphotonics

Morphotonics makes large-area nanoimprint lithography equipment for manufacturers of optical components, including display waveguides and data-center photonics.

>€40MSeries B
Participant
H2SITE

H2SITE builds membrane reactors and separators that produce high-purity hydrogen from transportable carriers and gas mixtures.

€42MSeries B+
Role not disclosed
Vitestro

Develops autonomous robotic phlebotomy devices for diagnostic blood collection

$70MSeries B
Role not disclosed
Pasqal

Pasqal develops quantum processors that use laser-controlled neutral atoms, with systems and algorithms for industrial and research customers.

€100MSeries B
Participant